{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:53:30Z","timestamp":1790481210195,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T00:00:00Z","timestamp":1453852800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T00:00:00Z","timestamp":1453852800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5T32DK007568-25"],"award-info":[{"award-number":["5T32DK007568-25"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007827","name":"American College of Gastroenterology","doi-asserted-by":"publisher","award":["2015 Junior Faculty Development Award"],"award-info":[{"award-number":["2015 Junior Faculty Development Award"]}],"id":[{"id":"10.13039\/100007827","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s10620-016-4035-3","type":"journal-article","created":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T09:55:28Z","timestamp":1453888528000},"page":"1406-1416","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Nonalcoholic Fatty Liver Disease: Key Considerations Before and After Liver Transplantation"],"prefix":"10.1007","volume":"61","author":[{"given":"Yuval A.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl L.","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8454-7086","authenticated-orcid":false,"given":"Cynthia A.","family":"Moylan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,27]]},"reference":[{"key":"4035_CR1","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1053\/jlts.2001.25453","volume":"7","author":"M Charlton","year":"2001","unstructured":"Charlton M, Kasparova P, Weston S, et al. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease. Liver Transpl. 2001;7:608\u2013614.","journal-title":"Liver Transpl"},{"key":"4035_CR2","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1053\/j.gastro.2011.06.061","volume":"141","author":"MR Charlton","year":"2011","unstructured":"Charlton MR, Burns JM, Pedersen RA, Watt KD, Heimbach JK, Dierkhising RA. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology. 2011;141:1249\u20131253.","journal-title":"Gastroenterology"},{"key":"4035_CR3","unstructured":"Taniguchi M. Liver transplantation in the MELD era\u2014analysis of the OPTN\/UNOS registry. Clin Transpl. 2012:41\u201365."},{"key":"4035_CR4","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1002\/hep.26986","volume":"59","author":"RJ Wong","year":"2014","unstructured":"Wong RJ, Cheung R, Ahmed A. Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S. Hepatology (Baltimore, Md.). 2014;59:2188\u20132195.","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"4035_CR5","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","volume":"148","author":"RJ Wong","year":"2015","unstructured":"Wong RJ, Aguilar M, Cheung R, et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology. 2015;148:547\u2013555.","journal-title":"Gastroenterology"},{"key":"4035_CR6","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/01.TP.0000436723.59879.01","volume":"96","author":"N Kemmer","year":"2013","unstructured":"Kemmer N, Neff GW, Franco E, et al. Nonalcoholic fatty liver disease epidemic and its implications for liver transplantation. Transplantation. 2013;96:860\u2013862.","journal-title":"Transplantation"},{"key":"4035_CR7","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/hep.510290347","volume":"29","author":"SH Caldwell","year":"1999","unstructured":"Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology (Baltimore, Md.). 1999;29:664\u2013669.","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"4035_CR8","first-page":"S11","volume":"40","author":"I Liou","year":"2006","unstructured":"Liou I, Kowdley KV. Natural history of nonalcoholic steatohepatitis. J Clin Gastroenterol. 2006;40:S11\u2013S16.","journal-title":"J Clin Gastroenterol"},{"key":"4035_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/lt.22435","volume":"18","author":"A Afzali","year":"2012","unstructured":"Afzali A, Berry K, Ioannou GN. Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States. Liver Transpl. 2012;18:29\u201337.","journal-title":"Liver Transpl"},{"key":"4035_CR10","doi-asserted-by":"publisher","first-page":"E606","DOI":"10.1111\/j.1399-0012.2011.01497.x","volume":"25","author":"CW Park","year":"2011","unstructured":"Park CW, Tsai NT, Wong LL. Implications of worse renal dysfunction and medical comorbidities in patients with NASH undergoing liver transplant evaluation: impact on MELD and more. Clin Transpl. 2011;25:E606\u2013E611.","journal-title":"Clin Transpl"},{"key":"4035_CR11","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1002\/hep.25855","volume":"56","author":"LB Vanwagner","year":"2012","unstructured":"Vanwagner LB, Bhave M, Te HS, Feinglass J, Alvarez L, Rinella ME. Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events. Hepatology (Baltimore, Md.). 2012;56:1741\u20131750.","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"4035_CR12","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1111\/j.1399-0012.2012.01669.x","volume":"26","author":"JC LaMattina","year":"2012","unstructured":"LaMattina JC, Foley DP, Fernandez LA, et al. Complications associated with liver transplantation in the obese recipient. Clin Transpl. 2012;26:910\u2013918.","journal-title":"Clin Transpl"},{"key":"4035_CR13","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/lt.23618","volume":"19","author":"AR Hakeem","year":"2013","unstructured":"Hakeem AR, Cockbain AJ, Raza SS, et al. Increased morbidity in overweight and obese liver transplant recipients: a single-center experience of 1325 patients from the United Kingdom. Liver Transpl. 2013;19:551\u2013562.","journal-title":"Liver Transpl"},{"key":"4035_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1053\/jhep.2002.30318","volume":"35","author":"S Nair","year":"2002","unstructured":"Nair S, Verma S, Thuluvath PJ. Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States. Hepatology (Baltimore, Md.). 2002;35:105\u2013109.","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"4035_CR15","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/lt.23680","volume":"19","author":"SE Perez-Protto","year":"2013","unstructured":"Perez-Protto SE, Quintini C, Reynolds LF, et al. Comparable graft and patient survival in lean and obese liver transplant recipients. Liver Transpl. 2013;19:907\u2013915.","journal-title":"Liver Transpl"},{"key":"4035_CR16","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1097\/SLA.0b013e31818a01ef","volume":"248","author":"DL Segev","year":"2008","unstructured":"Segev DL, Thompson RE, Locke JE, et al. Prolonged waiting times for liver transplantation in obese patients. Ann Surg. 2008;248:863\u2013870.","journal-title":"Ann Surg"},{"key":"4035_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.5500\/wjt.v5.i3.95","volume":"5","author":"S Ayloo","year":"2015","unstructured":"Ayloo S, Armstrong J, Hurton S, Molinari M. Obesity and liver transplantation. World J Transpl. 2015;5:95\u2013101.","journal-title":"World J Transpl"},{"key":"4035_CR18","doi-asserted-by":"publisher","first-page":"839275","DOI":"10.1155\/2013\/839275","volume":"2013","author":"S Hafeez","year":"2013","unstructured":"Hafeez S, Ahmed MH. Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance? J Obes. 2013;2013:839275.","journal-title":"J Obes"},{"key":"4035_CR19","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s11695-014-1430-8","volume":"25","author":"A Lazzati","year":"2015","unstructured":"Lazzati A, Iannelli A, Schneck AS, et al. Bariatric surgery and liver transplantation: a systematic review a new frontier for bariatric surgery. Obes Surg. 2015;25:134\u2013142.","journal-title":"Obes Surg"},{"key":"4035_CR20","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.soard.2013.02.013","volume":"9","author":"MY Lin","year":"2013","unstructured":"Lin MY, Tavakol MM, Sarin A, et al. Laparoscopic sleeve gastrectomy is safe and efficacious for pretransplant candidates. Surg Obes Relat Dis. 2013;9:653\u2013658.","journal-title":"Surg Obes Relat Dis"},{"key":"4035_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2015.09.017","author":"A Lonardo","year":"2015","unstructured":"Lonardo A, Sookoian S, Pirola CJ, Targher G. Non-alcoholic fatty liver disease and risk of cardiovascular disease. Metabolism. 2015. doi: 10.1016\/j.metabol.2015.09.017 .","journal-title":"Metabolism"},{"key":"4035_CR22","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.amjcard.2011.07.013","volume":"108","author":"S Patel","year":"2011","unstructured":"Patel S, Kiefer TL, Ahmed A, et al. Comparison of the frequency of coronary artery disease in alcohol-related versus non-alcohol-related endstage liver disease. Am J Cardiol. 2011;108:1552\u20131555.","journal-title":"Am J Cardiol"},{"key":"4035_CR23","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.jhep.2010.11.003","volume":"54","author":"C Ripoll","year":"2011","unstructured":"Ripoll C, Yotti R, Bermejo J, Banares R. The heart in liver transplantation. J Hepatol. 2011;54:810\u2013822.","journal-title":"J Hepatol"},{"key":"4035_CR24","first-page":"614781","volume":"2012","author":"EJ Carey","year":"2012","unstructured":"Carey EJ, Aqel BA, Byrne TJ, et al. Pretransplant fasting glucose predicts new-onset diabetes after liver transplantation. J Transpl. 2012;2012:614781.","journal-title":"J Transpl"},{"key":"4035_CR25","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1097\/TP.0b013e31819cc3e6","volume":"87","author":"C Park","year":"2009","unstructured":"Park C, Hsu C, Neelakanta G, et al. Severe intraoperative hyperglycemia is independently associated with surgical site infection after liver transplantation. Transplantation. 2009;87:1031\u20131036.","journal-title":"Transplantation"},{"key":"4035_CR26","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1111\/ajt.12762","volume":"14","author":"JC Lai","year":"2014","unstructured":"Lai JC, Feng S, Terrault NA, Lizaola B, Hayssen H, Covinsky K. Frailty predicts waitlist mortality in liver transplant candidates. Am J Transpl. 2014;14:1870\u20131879.","journal-title":"Am J Transpl"},{"key":"4035_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3109\/07853890.2011.561363","volume":"43","author":"VG Athyros","year":"2011","unstructured":"Athyros VG, Tziomalos K, Daskalopoulos GN, Karagiannis A, Mikhailidis DP. Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone? Ann Med. 2011;43:167\u2013171.","journal-title":"Ann Med"},{"key":"4035_CR28","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1002\/lt.24307","volume":"21","author":"AJ Kwong","year":"2015","unstructured":"Kwong AJ, Lai JC, Dodge JL, Roberts JP. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score. Liver Transpl. 2015;21:1403\u20131409.","journal-title":"Liver Transpl"},{"key":"4035_CR29","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.cgh.2011.04.007","volume":"9","author":"JG O\u2019Leary","year":"2011","unstructured":"O\u2019Leary JG, Landaverde C, Jennings L, Goldstein RM, Davis GL. Patients with NASH and cryptogenic cirrhosis are less likely than those with hepatitis C to receive liver transplants. Clin Gastroenterol Hepatol. 2011;9:700\u2013704.e701.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4035_CR30","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/ctr.12364","volume":"28","author":"RJ Wong","year":"2014","unstructured":"Wong RJ, Chou C, Bonham CA, Concepcion W, Esquivel CO, Ahmed A. Improved survival outcomes in patients with non-alcoholic steatohepatitis and alcoholic liver disease following liver transplantation: an analysis of 2002\u20132012 United Network for Organ Sharing data. Clin Transpl. 2014;28:713\u2013721.","journal-title":"Clin Transpl"},{"key":"4035_CR31","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/j.1600-6143.2009.02590.x","volume":"9","author":"SM Malik","year":"2009","unstructured":"Malik SM, deVera ME, Fontes P, Shaikh O, Ahmad J. Outcome after liver transplantation for NASH cirrhosis. Am J Transpl. 2009;9:782\u2013793.","journal-title":"Am J Transpl"},{"key":"4035_CR32","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1097\/MCG.0b013e3181eeaff0","volume":"45","author":"AS Barritt","year":"2011","unstructured":"Barritt AS, Dellon ES, Kozlowski T, Gerber DA, Hayashi PH. The influence of nonalcoholic fatty liver disease and its associated comorbidities on liver transplant outcomes. J Clin Gastroenterol. 2011;45:372\u2013378.","journal-title":"J Clin Gastroenterol"},{"key":"4035_CR33","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1097\/SLA.0b013e31826b4b7e","volume":"256","author":"VG Agopian","year":"2012","unstructured":"Agopian VG, Kaldas FM, Hong JC, et al. Liver transplantation for nonalcoholic steatohepatitis: the new epidemic. Ann Surg. 2012;256:624\u2013633.","journal-title":"Ann Surg"},{"key":"4035_CR34","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1002\/lt.21927","volume":"15","author":"V Bhagat","year":"2009","unstructured":"Bhagat V, Mindikoglu AL, Nudo CG, Schiff ER, Tzakis A, Regev A. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease. Liver Transpl. 2009;15:1814\u20131820.","journal-title":"Liver Transpl"},{"key":"4035_CR35","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.1477-2574.2012.00497.x","volume":"14","author":"C Kennedy","year":"2012","unstructured":"Kennedy C, Redden D, Gray S, et al. Equivalent survival following liver transplantation in patients with non-alcoholic steatohepatitis compared with patients with other liver diseases. HPB. 2012;14:625\u2013634.","journal-title":"HPB"},{"key":"4035_CR36","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.cgh.2013.09.023","volume":"12","author":"X Wang","year":"2014","unstructured":"Wang X, Li J, Riaz DR, Shi G, Liu C, Dai Y. Outcomes of liver transplantation for nonalcoholic steatohepatitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014;12:394\u2013402.e391.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4035_CR37","doi-asserted-by":"publisher","first-page":"e1001680","DOI":"10.1371\/journal.pmed.1001680","volume":"11","author":"G Musso","year":"2014","unstructured":"Musso G, Gambino R, Tabibian JH, et al. Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis. PLoS Med. 2014;11:e1001680.","journal-title":"PLoS Med"},{"key":"4035_CR38","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1002\/lt.22382","volume":"17","author":"DD Houlihan","year":"2011","unstructured":"Houlihan DD, Armstrong MJ, Davidov Y, et al. Renal function in patients undergoing transplantation for nonalcoholic steatohepatitis cirrhosis: time to reconsider immunosuppression regimens? Liver Transpl. 2011;17:1292\u20131298.","journal-title":"Liver Transpl"},{"key":"4035_CR39","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/TP.0000000000000048","volume":"98","author":"AK Singal","year":"2014","unstructured":"Singal AK, Salameh H, Kuo YF, Wiesner RH. Evolving frequency and outcomes of simultaneous liver kidney transplants based on liver disease etiology. Transplantation. 2014;98:216\u2013221.","journal-title":"Transplantation"},{"key":"4035_CR40","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1002\/hep.25536","volume":"55","author":"SK Reddy","year":"2012","unstructured":"Reddy SK, Steel JL, Chen HW, et al. Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease. Hepatology (Baltimore, Md.). 2012;55:1809\u20131819.","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"4035_CR41","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/hep.28123","volume":"62","author":"ZM Younossi","year":"2015","unstructured":"Younossi ZM, Otgonsuren M, Henry L, Venkatesan C, et al. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009. Hepatology (Baltimore, Md.). 2015;62:1723\u20131730.","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"4035_CR42","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1002\/lt.20298","volume":"10","author":"G Therapondos","year":"2004","unstructured":"Therapondos G, Flapan AD, Plevris JN, Hayes PC. Cardiac morbidity and mortality related to orthotopic liver transplantation. Liver Transpl. 2004;10:1441\u20131453.","journal-title":"Liver Transpl"},{"key":"4035_CR43","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1111\/liv.12872","volume":"35","author":"LB VanWagner","year":"2015","unstructured":"VanWagner LB, Lapin B, Skaro AI, Lloyd-Jones DM, et al. Impact of renal impairment on cardiovascular disease mortality after liver transplantation for nonalcoholic steatohepatitis cirrhosis. Liver Int. 2015;35:2575\u20132583.","journal-title":"Liver Int"},{"key":"4035_CR44","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1002\/lt.23499","volume":"18","author":"DT Patil","year":"2012","unstructured":"Patil DT, Yerian LM. Evolution of nonalcoholic fatty liver disease recurrence after liver transplantation. Liver Transpl. 2012;18:1147\u20131153.","journal-title":"Liver Transpl"},{"key":"4035_CR45","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1111\/j.1600-6143.2004.00432.x","volume":"4","author":"A Burke","year":"2004","unstructured":"Burke A, Lucey MR. Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation. Am J Transpl. 2004;4:686\u2013693.","journal-title":"Am J Transpl"},{"key":"4035_CR46","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/lt.22198","volume":"17","author":"I Laish","year":"2011","unstructured":"Laish I, Braun M, Mor E, Sulkes J, Harif Y, Ben Ari Z. Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events. Liver Transpl. 2011;17:15\u201322.","journal-title":"Liver Transpl"},{"key":"4035_CR47","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1111\/j.1600-6143.2006.01360.x","volume":"6","author":"VC McAlister","year":"2006","unstructured":"McAlister VC, Haddad E, Renouf E, Malthaner RA, Kjaer MS, Gluud LL. Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis. Am J Transpl. 2006;6:1578\u20131585.","journal-title":"Am J Transpl"},{"key":"4035_CR48","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/ajg.2009.717","volume":"105","author":"J Dumortier","year":"2010","unstructured":"Dumortier J, Giostra E, Belbouab S, et al. Non-alcoholic fatty liver disease in liver transplant recipients: another story of \u201cseed and soil\u201d. Am J Gastroenterol. 2010;105:613\u2013620.","journal-title":"Am J Gastroenterol"},{"key":"4035_CR49","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/lt.22004","volume":"16","author":"K Yalamanchili","year":"2010","unstructured":"Yalamanchili K, Saadeh S, Klintmalm GB, Jennings LW, Davis GL. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease. Liver Transpl. 2010;16:431\u2013439.","journal-title":"Liver Transpl"},{"key":"4035_CR50","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1097\/TP.0b013e31820b6b84","volume":"91","author":"P Dureja","year":"2011","unstructured":"Dureja P, Mellinger J, Agni R, et al. NAFLD recurrence in liver transplant recipients. Transplantation. 2011;91:684\u2013689.","journal-title":"Transplantation"},{"key":"4035_CR51","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1053\/jlts.2001.23011","volume":"7","author":"MJ Contos","year":"2001","unstructured":"Contos MJ, Cales W, Sterling RK, et al. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis. Liver Transpl. 2001;7:363\u2013373.","journal-title":"Liver Transpl"},{"key":"4035_CR52","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/lt.20932","volume":"13","author":"S Seo","year":"2007","unstructured":"Seo S, Maganti K, Khehra M, et al. De novo nonalcoholic fatty liver disease after liver transplantation. Liver Transpl. 2007;13:844\u2013847.","journal-title":"Liver Transpl"},{"key":"4035_CR53","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1002\/lt.23936","volume":"20","author":"M Vallin","year":"2014","unstructured":"Vallin M, Guillaud O, Boillot O, Hervieu V, Scoazec JY, Dumortier J. Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation: natural history based on liver biopsy analysis. Liver Transpl. 2014;20:1064\u20131071.","journal-title":"Liver Transpl"},{"key":"4035_CR54","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.cgh.2013.06.025","volume":"11","author":"A Finkenstedt","year":"2013","unstructured":"Finkenstedt A, Auer C, Glodny B, et al. Patatin-like phospholipase domain-containing protein 3 rs738409-G in recipients of liver transplants is a risk factor for graft steatosis. Clin Gastroenterol Hepatol. 2013;11:1667\u20131672.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4035_CR55","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/hep.23276","volume":"51","author":"K Promrat","year":"2010","unstructured":"Promrat K, Kleiner DE, Niemeier HM, et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology (Baltimore, Md.). 2010;51:121\u2013129.","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"4035_CR56","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.jhep.2010.11.004","volume":"54","author":"L McCormack","year":"2011","unstructured":"McCormack L, Dutkowski P, El-Badry AM, Clavien PA. Liver transplantation using fatty livers: always feasible? J Hepatol. 2011;54:1055\u20131062.","journal-title":"J Hepatol"},{"key":"4035_CR57","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jhep.2006.07.017","volume":"45","author":"A Nocito","year":"2006","unstructured":"Nocito A, El-Badry AM, Clavien PA. When is steatosis too much for transplantation? J Hepatol. 2006;45:494\u2013499.","journal-title":"J Hepatol"},{"key":"4035_CR58","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1002\/lt.21668","volume":"14","author":"F Durand","year":"2008","unstructured":"Durand F, Renz JF, Alkofer B, et al. Report of the Paris consensus meeting on expanded criteria donors in liver transplantation. Liver Transpl. 2008;14:1694\u20131707.","journal-title":"Liver Transpl"},{"key":"4035_CR59","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/lt.20807","volume":"12","author":"JD Perkins","year":"2006","unstructured":"Perkins JD. Saying \u201cyes\u201d to obese living liver donors: short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation. Liver Transpl. 2006;12:1012\u20131013.","journal-title":"Liver Transpl"},{"key":"4035_CR60","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.jhep.2005.07.032","volume":"44","author":"N Selzner","year":"2006","unstructured":"Selzner N, Selzner M, Jochum W, Amann-Vesti B, Graf R, Clavien PA. Mouse livers with macrosteatosis are more susceptible to normothermic ischemic injury than those with microsteatosis. J Hepatol. 2006;44:694\u2013701.","journal-title":"J Hepatol"},{"key":"4035_CR61","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/lt.22085","volume":"16","author":"AL Spitzer","year":"2010","unstructured":"Spitzer AL, Lao OB, Dick AA, et al. The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment. Liver Transpl. 2010;16:874\u2013884.","journal-title":"Liver Transpl"},{"key":"4035_CR62","doi-asserted-by":"publisher","first-page":"15532","DOI":"10.3748\/wjg.v20.i42.15532","volume":"20","author":"P Zezos","year":"2014","unstructured":"Zezos P, Renner EL. Liver transplantation and non-alcoholic fatty liver disease. World J Gastroenterol. 2014;20:15532\u201315538.","journal-title":"World J Gastroenterol"},{"key":"4035_CR63","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1097\/TP.0b013e31828d1588","volume":"95","author":"JS Ahn","year":"2013","unstructured":"Ahn JS, Sinn DH, Gwak GY, et al. Steatosis among living liver donors without evidence of fatty liver on ultrasonography: potential implications for preoperative liver biopsy. Transplantation. 2013;95:1404\u20131409.","journal-title":"Transplantation"},{"key":"4035_CR64","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1097\/01.tp.0000166009.77444.f3","volume":"80","author":"M Nakamuta","year":"2005","unstructured":"Nakamuta M, Morizono S, Soejima Y, et al. Short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation. Transplantation. 2005;80:608\u2013612.","journal-title":"Transplantation"},{"key":"4035_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/hpb.12258","volume":"17","author":"MJ Chu","year":"2015","unstructured":"Chu MJ, Vather R, Hickey AJ, Phillips AR, Bartlett AS. Impact of ischaemic preconditioning on experimental steatotic livers following hepatic ischaemia-reperfusion injury: a systematic review. HPB. 2015;17:1\u201310.","journal-title":"HPB"},{"key":"4035_CR66","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/00000658-200008000-00001","volume":"232","author":"PA Clavien","year":"2000","unstructured":"Clavien PA, Yadav S, Sindram D, Bentley RC. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg. 2000;232:155\u2013162.","journal-title":"Ann Surg"},{"key":"4035_CR67","doi-asserted-by":"crossref","unstructured":"Gurusamy KS, Kumar Y, Sharma D, Davidson BR. Ischaemic preconditioning for liver transplantation. The Cochrane Database of Systematic Reviews. 2008:Cd006315.","DOI":"10.1002\/14651858.CD006315.pub2"},{"key":"4035_CR68","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1111\/j.1600-6143.2009.02680.x","volume":"9","author":"A Franchello","year":"2009","unstructured":"Franchello A, Gilbo N, David E, et al. Ischemic preconditioning (IP) of the liver as a safe and protective technique against ischemia\/reperfusion injury (IRI). Am J Transpl. 2009;9:1629\u20131639.","journal-title":"Am J Transpl"},{"key":"4035_CR69","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1038\/cddis.2010.89","volume":"2","author":"D Degli Esposti","year":"2011","unstructured":"Degli Esposti D, Sebagh M, Pham P, et al. Ischemic preconditioning induces autophagy and limits necrosis in human recipients of fatty liver grafts, decreasing the incidence of rejection episodes. Cell Death Dis. 2011;2:e111.","journal-title":"Cell Death Dis"},{"key":"4035_CR70","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1097\/SLA.0b013e31818f3dda","volume":"248","author":"B Beck-Schimmer","year":"2008","unstructured":"Beck-Schimmer B, Breitenstein S, Urech S, et al. A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic. Ann Surg. 2008;248:909\u2013918.","journal-title":"Ann Surg"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-016-4035-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-016-4035-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-016-4035-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-016-4035-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T14:07:57Z","timestamp":1654178877000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-016-4035-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,27]]},"references-count":70,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["4035"],"URL":"https:\/\/doi.org\/10.1007\/s10620-016-4035-3","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,27]]},"assertion":[{"value":"12 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}